Published in Br Med J (Clin Res Ed) on May 14, 1988
Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases. Clin Exp Immunol (1991) 1.12
Indications for IVIG in rheumatic diseases. Rheumatology (Oxford) (2014) 0.77
High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet (1981) 4.39
Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med (1982) 2.83
High-dose intravenous gamma globulin for autoimmune neutropenia. N Engl J Med (1982) 1.29
High-dose intravenous gammaglobulin for myasthenia gravis. Lancet (1984) 1.14
New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion (1998) 1.39
Autoimmune thrombocytopenia: detection of platelet autoantibodies with the suspension immunofluorescence test. Br J Haematol (1980) 1.33
Specificity of autoantibodies in autoimmune thrombocytopenia. Blood (1982) 1.10
Evaluation of automated nucleic acid extraction devices for application in HCV NAT. Transfusion (2000) 1.00
Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia. Blood (1993) 0.93
Studies on quinine- and quinidine-dependent antibodies against platelets and their reaction with platelets in the Bernard-Soulier syndrome. Br J Haematol (1982) 0.88
Maternal autoimmune thrombocytopenia and the newborn. Br Med J (Clin Res Ed) (1981) 0.87
Max(a), a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopenia. Blood (1995) 0.87
What is the best predictor of the severity of ABO-haemolytic disease of the newborn? Lancet (1988) 0.86
B precursor acute lymphoblastic leukemia third complementarity-determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life. Eur J Immunol (1994) 0.83
Preclinical studies with radiolabeled monoclonal antibodies for treatment of patients with B-cell malignancies. Cancer (1994) 0.82
Effect of the binding of anti-Zwa antibodies on platelet function. Vox Sang (1984) 0.82
Neonatal alloimmune thrombocytopenia: detection and characterization of the responsible antibodies by the platelet immunofluorescence test. Blood (1981) 0.81
Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia. Leukemia (1997) 0.81
The Evans syndrome: characterization of the responsible autoantibodies. Br J Haematol (1982) 0.80
Idiopathic thrombocytopenic purpura in children; detection of platelet autoantibodies by immunofluorescence. Scand J Haematol (1981) 0.79
Frequent ongoing T-cell receptor rearrangements in childhood B-precursor acute lymphoblastic leukemia: implications for monitoring minimal residual disease. Blood (1995) 0.79
Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn. Br J Haematol (1988) 0.78
Absence of platelet-specific alloantigens in Glanzmann's thrombasthenia. Blood (1981) 0.78
Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice. Leukemia (1996) 0.77
Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody. Blood (1994) 0.77
Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis. Exp Hematol (1990) 0.77
Neonatal neutropenia due to maternal autoantibodies against neutrophils. Br Med J (Clin Res Ed) (1983) 0.76
Alpha-hemolytic streptococcal septicemia with severe complications during neutropenia in childhood cancer. Pediatr Hematol Oncol (1987) 0.76
Blood transfusion in premature or young infants with polyagglutination and activation of the T antigen. Vox Sang (1999) 0.75
Continuous venous access in children for long-term chemotherapy by means of an implantable system. J Pediatr Surg (1986) 0.75
Renal embolisation in Glanzmann's thrombasthenia. Br Med J (1980) 0.75
Neonatal alloimmune thrombocytopenia complicated by maternal autoimmune thrombocytopenia. Br Med J (1980) 0.75
Bone marrow relapse occurring as first relapse in children with acute lymphoblastic leukemia. Med Pediatr Oncol (1990) 0.75
Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia. J Hematother (1997) 0.75
[Significance of recurrence in children with acute lymphatic leukemia]. Tijdschr Kindergeneeskd (1988) 0.75
[Treatment of acute non-lymphatic leukemia in children]. Ned Tijdschr Geneeskd (1979) 0.75
Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodeficient patient. Bone Marrow Transplant (2003) 0.75
Detection of carriers in Glanzmann's thrombasthenia. Thromb Haemost (1983) 0.75
[Contribution of bone marrow transplantation to the treatment of children with leukemia]. Tijdschr Kindergeneeskd (1988) 0.75
A new low-incidence antigen in the Kell blood group system: VLAN (KEL25). Vox Sang (1996) 0.75
IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL. Leukemia (1995) 0.75
Mitoxantrone is effective in treating childhood T-cell lymphoma/T-cell acute lymphoblastic leukemia. Cancer (1995) 0.75
[Neutropenia and thrombocytopenia in newborn infants caused by allo-antibodies]. Ned Tijdschr Geneeskd (1980) 0.75
[Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP]. Ned Tijdschr Geneeskd (1975) 0.75
A simple strategy to look back on posttransfusion hepatitis B in a multitransfused patient. Vox Sang (1998) 0.75
Biochemical consequences of 2'-deoxycoformycin treatment in a patient with T-cell lymphoma. Some unusual findings. Cancer (1987) 0.75
Primary and secondary autoimmune thrombocytopenia. A serological and clinical analysis. Scand J Haematol (1982) 0.75
[Autologous bone marrow transplantation in the treatment of children with neuroblastoma; 30 patients in 10 years]. Ned Tijdschr Geneeskd (1994) 0.75
PCR-positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B-cell acute leukaemia. Br J Haematol (1997) 0.75
Human immunodeficiency virus (HIV) antibodies detected by new assays that are enhanced for HIV-1 subtype O. Transfusion (1997) 0.75
Immunochemical characterization of platelet-specific alloantigens. Scand J Haematol (1984) 0.75
Eosinophilic meningitis preceding meningeal relapse in a child with acute lymphoblastic leukemia: abnormal nucleotide content of eosinophils. Pediatr Hematol Oncol (1987) 0.75
Sensitive methods for determining subclasses of IgG anti-A and anti-B in sera of blood-group-O women with a blood-group-A or -B child. Br J Haematol (1987) 0.75
[Experiences with a completely implantable intravenous system in children]. Tijdschr Kindergeneeskd (1986) 0.75
The use of immunorosettes for purging of bone marrow in childhood cancer. Prog Clin Biol Res (1990) 0.75
Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia. Leukemia (1995) 0.75
[Carrier state of hemophilia]. Ned Tijdschr Geneeskd (1984) 0.75
The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts. Prog Clin Biol Res (1994) 0.75
[The treatment of children with idiopathic thrombocytopenic purpura using high doses of intravenously administered gammaglobulins]. Ned Tijdschr Geneeskd (1984) 0.75
The prevention of oral complications in bone-marrow transplantations by means of oral hygiene and dental intervention. Neth J Med (1989) 0.75
The significance of an isolated central nervous system relapse, occurring as first relapse in children with acute lymphoblastic leukemia. Cancer (1989) 0.75
Neuroblastoma purging by immunorosette depletion. Prog Clin Biol Res (1992) 0.75
[Children with acute lymphoblastic leukemia: prognostic significance of polymerase-chain-reaction analysis of minimal residual disease]. Ned Tijdschr Geneeskd (1996) 0.75
[Bleomycin and pulmonary function changes in children with malignant lymphomas]. Ned Tijdschr Geneeskd (1991) 0.75